Sinocelltech Group (SHSE:688520) Change In Payables And Accrued Expense : ¥0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Sinocelltech Group Change In Payables And Accrued Expense?

Sinocelltech Group's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2024 was ¥0 Mil. It means Sinocelltech Group's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Mar. 2024 .

Sinocelltech Group's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was ¥0 Mil. It means Sinocelltech Group's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Dec. 2023 .

Sinocelltech Group Change In Payables And Accrued Expense Historical Data

The historical data trend for Sinocelltech Group's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinocelltech Group Change In Payables And Accrued Expense Chart

Sinocelltech Group Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Sinocelltech Group Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Sinocelltech Group Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Sinocelltech Group Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Sinocelltech Group's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinocelltech Group (SHSE:688520) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinocelltech Group Ltd (SHSE:688520) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Kechuang Seventh Street, Beijing Economic and Technological Development Zone, Room 307, Building 5, Courtyard 31, Beijing, CHN, 100176

Website

http://www.sinocelltech.com

Sinocelltech Group Ltd is engaged in development and industrialization of biopharmaceutical products such as monoclonal antibodies, recombinant proteins and vaccines. The company has developed technology platforms in protein expression vectors, cell line development, serum-free medium development, stoichiometrically controlled fed-batch cell culture, process scale-up, and protein purification. Its capacities include stable CHO cell line development, cell banking and certification, serum-free and protein-free culture medium development, fed-batch cell culture process development, optimization, and process scale-up; protein purification development, and large scale production.

Executives

Xie Liang Zhi

Director

Sinocelltech Group (SHSE:688520) Headlines

No Headlines